Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001374266 | SCV001571070 | pathogenic | Nephronophthisis 15 | 2025-01-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg4*) in the CEP164 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP164 are known to be pathogenic (PMID: 22863007, 28125082, 32367404, 34132027, 34499853). This variant is present in population databases (rs765277720, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CEP164-related conditions. ClinVar contains an entry for this variant (Variation ID: 1064314). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV001374266 | SCV001752513 | likely pathogenic | Nephronophthisis 15 | 2021-06-30 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003229052 | SCV003926121 | uncertain significance | not provided | 2022-11-21 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge |